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Abstract
Monomethyl branched-chain fatty acids (mmBCFAs) are essential for Caenorhabditis elegans growth and development. To
identify factors acting downstream of mmBCFAs for their function in growth regulation, we conducted a genetic screen for
suppressors of the L1 arrest that occurs in animals depleted of the 17-carbon mmBCFA C17ISO. Three of the suppressor
mutations defined an unexpected player, the P-type ATPase TAT-2, which belongs to the flippase family of proteins that are
implicated in mediating phospholipid bilayer asymmetry. We provide evidence that TAT-2, but not other TAT genes, has a
specific role in antagonizing the regulatory activity of mmBCFAs in intestinal cells. Interestingly, we found that mutations in
tat-2 also suppress the lethality caused by inhibition of the first step in sphingolipid biosynthesis. We further showed that
the fatty acid side-chains of glycosylceramides contain 20%–30% mmBCFAs and that this fraction is greatly diminished in
the absence of mmBCFA biosynthesis. These results suggest a model in which a C17ISO-containing sphingolipid may
mediate the regulatory functions of mmBCFAs and is negatively regulated by TAT-2 in intestinal cells. This work indicates a
novel connection between a P-type ATPase and the critical regulatory function of a specific fatty acid.
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Introduction
Lipids play many critical roles in cellular function ranging from
providing structural support within cell membranes to mediating
signaling events. The importance of the particular fatty acid
constituents of complex lipids is only beginning to be understood.
While extensive analyses have been conducted to elucidate the
specific roles of straight-chain saturated and unsaturated fatty
acids, there is little known about the roles of monomethyl
branched-chain fatty acids (mmBCFAs) in animals. We have
previously identified an essential role for mmBCFAs in regulating
post-embryonic development in the model organism C. elegans,
where the deletion of elo-5, a gene encoding a very long chain fatty
acid (VLCFA) elongase, causes larval arrest and death. When the
fatty acid composition of worms lacking functional ELO-5 was
compared to that of wild-type worms, two detectable mmBCFAs
(C15ISO and C17ISO) were missing. In addition, when the ELO-
5 deficient strain was supplemented with exogenous C15ISO and
C17ISO, the nematodes recovered from larval arrest and were
able to proliferate similar to wild-type worms [1]. The L1 arrest
that occurs in the absence of C17ISO is strikingly similar to the L1
diapause that occurs in the absence of food [2]. In both cases, the
worms arrest at an early L1 stage, just after hatching and prior to
the first M cell division, and the arrest is reversible upon
restoration of the depleted component. The DAF-2/DAF-16
insulin-signaling pathway has been shown to be involved in the
starvation-induced arrest [3]. Further characterization revealed
that C17ISO may play a critical role in activating post-embryonic
development in C. elegans through a novel pathway that is
independent of the DAF-2/DAF-16 food-sensing pathway [2].
CKI-1 is a cyclin-dependent kinase inhibitor that has been shown
to be required for exit from the cell cycle and is likely a critical
downstream target of DAF-16 with its expression level normally
decreasing during L1 development [3,4]. The L1 arrested larvae
seen in the absence of C17ISO exhibit stable expression of CKI-1
[2], suggesting that C17ISO deprivation may contribute to the
upregulation of CKI-1 through a previously uncharacterized,
DAF-16-independent signaling pathway. Consistent with the
critical regulatory role played by mmBCFAs in worms, we have
found that mmBCFA homeostasis is maintained through a
feedback regulatory mechanism involving SBP-1 [1,2]. SBP-1,
the C. elegans orthologue of mammalian SREBP-1c [5], may sense
a deficiency in mmBCFA levels and respond by upregulating the
transcription of monomethyl branched-chain fatty acid biosynthe-
sis enzymes including ELO-5 and ACS-1, a long chain fatty acid
acyl-CoA ligase.
Cell membranes are generally asymmetric in nature, containing
higher levels of aminophospholipids on the cytosolic leaflet and
exhibiting an enrichment of sphingolipids and choline-containing
lipids on the extracellular/lumenal leaflet [6]. Alterations in cell
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associated with various normal and pathological outcomes
including apoptosis and platelet activation [7,8]. However, with
the exception of phosphatidylserine externalization during apo-
ptosis, the precise mechanisms by which the asymmetric
distribution of lipids across cellular membranes regulates mem-
brane and lipid functions are not well understood. A subfamily of
P-type ATPases, called aminophospholipid translocases or flip-
pases, are proteins that are thought to contribute to this
asymmetry in an ATP-dependent manner [9,10]. The postulated
function of flippases is to aid in the inward movement of
phosphatidylserine (PS) and phosphatidylethanolamine (PE) from
the extracellular or lumenal leaflet to the cytosolic leaflet of cellular
membranes. To date, there have been very limited functional
studies on this family of proteins in animals. In yeast, an
aminophospholipid translocase, DRS2, has been shown to mediate
the flipping of a fluorescent analog of PS in isolated late Golgi
membranes [11]. DRS2 mutants have been shown to have defects
in protein trafficking at the trans Golgi network [12,13], suggesting
that membrane asymmetry may be important for intracellular
transport events. In humans, mutations in FIC1, a putative
aminophospholipid translocase, have been found in familial
hereditary cholestasis [14]. However, the mechanism by which
this mutation contributes to the pathology has yet to be elucidated.
The C. elegans genome contains six predicted aminophospholipid
translocases known as tat-1 through tat-6 [15,16]. Recent work
based on the expression pattern of reporter transgenes suggests
that each of the TAT proteins may have distinct functions and
four of them are not essential under regular growth conditions
[17]. Mutations in tat-2, tat-3 and tat-4 genes were shown to
enhance the sensitivity of C. elegans to cholesterol deficiency [17].
TAT-1 has been shown to be involved in the movement of
phosphatidyl serine during apoptosis and regulate lysosome
biogenesis and endocytosis [16,18,19]. However, the cellular and
physiological functions of TAT proteins largely remain to be
explored in animal cells.
Sphingolipids are structurally diverse lipids that can have
equally diverse functions. In addition to altering membrane
content, sphingolipid metabolites have also been implicated in
intracellular and extracellular signaling (reviewed in [20]). The
rate-limiting step in sphingolipid biosynthesis is the condensation
of serine with fatty acid-CoA to generate 3-ketosphinganine, a
precursor to the sphingoid base. This step is catalyzed by serine
palmitoyltransferase (SPT) and as the name implies, the fatty acyl-
CoA substrate is generally palmitoyl-CoA [21,22]. In C. elegans,
sphingoid bases of glucosylceramides and sphingomyelin have
been shown to exclusively contain a branched-chain base
constituent, perhaps produced from an iso-branched fatty acid
[23]. This may suggest a potential link between the essential
function of mmBCFAs and sphingolipids.
In this paper, we describe the identification and characteriza-
tion of mutations in the tat-2 P-type ATPase gene as suppressors of
the L1 arrest caused by depleting the mmBCFA, C17ISO. We
provide evidence that TAT-2 acts in intestinal cells to specifically
antagonize mmBCFA activity in regulating post-embryonic
growth, and such a function may be mediated by an mmBCFA-
containing sphingolipid. This work provides a novel link between
the critical regulatory function of a specific fatty acid and the
maintenance of lipid bilayer asymmetry.
Results
Suppressor mutations define a gene that may act
downstream of C17ISO to antagonize its function in
regulating L1 growth
The elo-5(gk208) deletion mutant animals die in various larval
stages and consequently do not reproduce. When the elo-5(gk208)
deletion worms are supplemented with C15ISO or C17ISO, they
grow to wild-type adults and can continue to grow and propagate
in the presence of this supplementation [1]. However, upon
supplementation with a short-chain mmBCFA, C13ISO, elo-
5(gk208) worms grow to wild-type adults in the first generation and
produce F1 progeny (Figure 1A). The progeny uniformly arrest in
the first larval stage for several days before dying. To identify genes
that may potentially act downstream of C17ISO to mediate this
regulatory function, we screened for suppressor mutations that
would allow C13ISO-supplemented elo-5(gk208) animals to grow
past the L1 stage in the F1 generation (Materials and Methods).
Among several suppressor mutations, three alleles were able to
grow indefinitely in the presence of C13ISO supplementation
(Figure 1B). Without any supplementation, these worms grew
similarly to wild type in the first generation, but their progeny
arrested and died as early larvae (Table 1), indicating that,
although the suppressor mutations were able to overcome the L1
arrest in the absence of the longer chain mmBCFA, C17ISO, they
were not able to bypass all mmBCFA functions.
Molecular cloning indicated that these three mutations are
alleles of a single gene, tat-2 (see below). We were able to conclude
that these three mutations are likely loss of function mutations in
the tat-2 gene and that loss of tat-2 gene function is responsible for
the suppressor phenotype based on results from the following three
sets of experiments. Firstly, we determined that tat-2 RNAi
phenocopies the mutations. When tat-2(RNAi), but no mmBCFA
supplementation, was applied, elo-5(gk208) deletion mutants grew
to healthy adults in the first generation and produced progeny that
were able to develop into egg-laying adults, with the next
generation arresting in early larval stages (Table 1). Secondly,
we acquired a 222-bp deletion mutation in tat-2, tm2332, from the
National Bioresource Project in Japan, and showed that it can also
suppress the L1 arrest phenotype of elo-5(RNAi). When treated
with elo-5(RNAi) in the absence of mmBCFA supplementation, tat-
2(tm2332) mutant worms grew to wild-type adults in the first
Author Summary
Fatty acids serve diverse functions in organisms, including
roles at the cell membrane to coordinate cell signaling
processes. Monomethyl branched-chain fatty acids
(mmBCFAs) are a special type of fatty acid that is
commonly present in animals. Because mmBCFAs are a
small component of the total fatty acid pool, their
functions have not been a major research focus and are
largely unclear. We tackled the problem using the
nematode C. elegans. Our laboratory previously found that
without mmBCFAs, worms cannot develop normally and
die. To understand how these obscure fatty acids perform
such important roles, we searched for other factors
involved in the process by conducting a mutagenesis
screen to uncover mutant worms that can recover the
ability to grow without the presence of mmBCFAs. We
found several such mutations in a single gene that codes
for a protein called TAT-2. TAT-2 is one of several poorly
understood P-type ATPases that likely help maintain the
proper lipid structure in cell membranes. Our work
indicates that TAT-2 antagonizes the growth regulatory
function of mmBCFAs in intestinal cells. Studies on how
mmBCFAs and this protein functionally interact explore a
novel, interesting, and important problem that is only
beginning to be understood.
TAT-2 Role in mmBCFA Function
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transferred to fresh elo-5 RNAi plates for multiple generations. The
stronger suppressing effect seen in this assay likely reflects that fact
that elo-5(RNAi) has a weaker mutant phenotype as that of elo-
5(gk208) [2]. A similar effect was seen with another tat-2 deletion
mutation, tm1773 (data not shown). Finally, we were able to rescue
Figure 1. Suppressor mutations relieve L1 arrest of elo-5(gk208) animals without recovering the ability to synthesize C15ISO or C17ISO.
(A)Imageofapopulationofelo-5(gk208)animalsgrownfromeggsonplatessupplementedwithC13ISO,showingP0adultsandarrestedL1larvaeoftheF1
generation on day 5. (B) Image of a population of elo-5(gk208); tat-2(ku452) animals grown from eggs on plates supplemented with C13ISO, showing P0
adults and mixed stage larvae of the F1 generation on day 5. (C) Comparison of mmBCFA composition in four strains of indicated genotypes grown on
plates supplemented withC13ISO. C15ISOand C17ISO are significantly decreased in elo-5(gk208) when compared towild-type worms, and remain at a low
levels in the strains in which either tat-2(ku452) or tat-2(tm2332) is coupled with the elo-5 mutation. The tat-2(tm2332) mutation alone does not cause a
decrease in C15ISO and C17ISO. Five replicates were done for each sample type. Data are expressed as a percentage of total fatty acids+/2SEM.
doi:10.1371/journal.pgen.1000589.g001
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role of ku449) by expressing the TAT-2 protein from a transgene
under the control of the putative TAT-2 promoter as described
below (Table 2). Therefore, combined with the finding that TAT-2
is not involved in the biosynthesis of mmBCFAs (see below), our
results indicate that TAT-2 plays a negative role in C17ISO-
mediated L1 growth regulation.
tat-2 encodes a putative P-type ATPase
To identify the gene defined by the suppressor mutations, we
mapped the mutations to the middle of chromosome IV using
genetic and single nucleotide polymorphism markers (Materials
and Methods; Figure 2A and 2B). Sequence analysis identified all
three alleles as distinct molecular lesions in the tat-2 gene: ku452,
ku449, and ku450 contained amino acid changes from Thr 412 to
Asp, Ser 510 to Leu, and Gly 617 to Glu, respectively (Figure 2C).
Upon examination of the tat-2 cDNA, we found that it coded for
an additional 92 amino acids not included in the protein predicted
by Wormbase (data not shown).
The protein encoded by tat-2 is a 1313-amino acid P-type
ATPase that belongs to a family of proteins also known as
flippases. Proteins with structural similarity to TAT-2 are found in
yeast, mammals and C. elegans (Figure 2C). The protein encoded by
tat-2 shows conservation of domains that are characteristic of P-
type ATPases as well as features that are specific to the Drs2p-
subfamily of ATPases. Drs2p and other P-type ATPases are 10-
pass transmembrane proteins with a cytoplasmic domain contain-
ing conserved residues that form an aspartyl-phosphate interme-
diate during ATP hydrolysis [24]. There are also two cytoplasmic
sequences specifically conserved in the Drs2p family of ATPases
[25]. The residue change in tat-2(ku452) (threonine 412 to
asparagine) is two residues away from the catalytic aspartate and
thus, may disrupt the catalytic function of the TAT-2 protein. This
mutation may be of particular interest because an analogous
mutation has been identified in patients diagnosed with familial
cholestasis, in which this conserved threonine is changed to a
methionine [26]. The tat-2(ku449) lesion (S510T) is in a
cytoplasmic domain that is conserved in Drs2p-like ATPases,
and the tat-2(ku450) lesion (G617E) affects a region that is not
obviously conserved (Figure 2).
tat-2(lf) does not alter mmBCFA biosynthesis or
absorption, nor does it bypass all mmBCFA functions
To determine that the suppressor effect is not due to a recovery
of C17ISO biosynthesis, we examined the fatty acid composition
of these mutants by gas chromatography (GC). We found that the
suppressor mutants grown in the presence of C13ISO did not
recover the ability to synthesize mmBCFAs (Figure 1C). The GC
analysis also detected statistically significant differences in the
levels of two other fatty acids, stearic acid (C18:0; P=.016) and
methyleneoctadecanoic acid (C19Delta; P=.0015) between wild-
type, elo-5(gk208), elo-5(gk208); tat-2(tm2332) and tat-2(tm2332)
animals. Because C19Delta was significantly increased in the tat-
2(tm2332); elo-5(gk208) mutants compared to elo-5(gk208) worms,
we supplemented this fatty acid to the food given to elo-5(gk208)
worms in the presence of C13ISO, but no rescue of the growth
arrest of elo-5(gk208) mutants was observed (data not shown).
Therefore, while these tat-2 mutations allow mmBCFA-deficient
animals to by-pass the L1 arrest, they do not do so by recovering
the ability to synthesize mmBCFAs, nor by increasing the levels of
other fatty acids.
Upon detailed examination of the tat-2(tm2332) single deletion
mutant, we saw no obvious abnormalities, including normal fatty
acid composition (data not shown; Supplemental Data; Figure 1).
When we constructed the complete double deletion mutant, tat-
2(tm2332);elo-5(gk208), we found that the animals behaved
similarly to the point mutants in that they can grow indefinitely
in the presence of C13ISO. However, a small proportion of worms
(,20%) grown without supplementation progressed an additional
generation to F2 prior to the arrest, instead of arresting in the F1
generation as seen with the point mutants (Table 1). These data
support the idea that the absence of tat-2 can suppress some, but
not all defects caused by mmBCFA deficiency. It also suggests that
in the absence of tat-2, C13ISO (at a low concentration) can
substitute for C17ISO in some post-embryonic developmental
aspects. One possibility is that, in tat-2(-) animals, the absorption of
C13ISO may be increased to achieve a higher cellular
concentration of C13ISO. We tested this by feeding high amounts
of supplemental C13ISO to tat-2(-) and N2 worms. By comparing
the fatty acid composition of these worms, we determined that
there was not a significant difference in absorption of C13ISO
(data not shown).
Table 1. Mutations in tat-2 suppress growth and
developmental defects caused by depleting mmBCFA.
Genotype and supplementation Generation Number Stage
(a)
Wild type (N2) Indefinite NA
elo-5(RNAi) F1 L1
tat-2(RNAi) Indefinite NA
elo-5(gk208) P0 L1–L4
elo-5(gk208)+C13ISO F1 L1
elo-5(gk208);tat-2(ku452) F1 L1–L3
elo-5(gk208);tat-2(ku452)+C13ISO Indefinite NA
tat-2(tm2332) Indefinite NA
elo-5(gk208);tat-2(RNAi) F2 L1–L3
elo-5(RNAi);tat-2(tm2332) .F4 L1–L3
elo-5(gk208);tat-2(tm2332)
(b) F2 L1
elo-5(gk208);tat-2(tm2332)+C13ISO Indefinite NA
All strains were grown from eggs isolated from gravid adults grown on OP50
supplemented with the mmBCFA-producing bacteria S. maltophilia and
released by alkaline hypochlorite treatment. NA: not applicable; these strains
did not arrest.
(a)Stage at which animals arrested growth.
(b)The elo-5(gk208);tat-2(tm2332) strain also contains the unc-5(e53) mutation.
doi:10.1371/journal.pgen.1000589.t001
Table 2. Expression of tat-2 cDNA in intestine, but not in
three other tissues, rescues the mutant effect of tat-2(ku449).
Promoter:Gene % F1 arrested as eggs/L1
tat-2:GFP 0 (n=297)
tat-2:tat-2 99.1 (n=444)
ges-1:tat-2 93.1 (n=562)
sth-1:tat-2 0 (n=383)
exc-5:tat-2 0 (n=172)
col-10:tat-2 1.2 (n=643)
All constructs were injected into the tat-2(ku449);elo-5(gk208) background.
Rescue was defined as the percentage of animals carrying the array (green) that
had returned to the phenotype of elo-5(gk208) animals grown on C13ISO.
doi:10.1371/journal.pgen.1000589.t002
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PLoS Genetics | www.plosgenetics.org 4 August 2009 | Volume 5 | Issue 8 | e1000589Figure 2. Positional cloning, protein alignment, and molecular lesions of tat-2 defined by suppressors of the L1 arrest phenotype of
elo-5(lf). (A) Schematic representation of the region of C. elegans chromosome IV that indicates the position of the relevant genes and the
phenotypic markers used for mapping. Also displayed are fosmids in the region, along with the area covered by the pJB18-rescuing construct.
Numbers in parentheses represent the number of rescued lines out of the total number of lines generated. Fosmid abbreviations are short for:
WRM0610bF10, WRM0640cG11, WRM0641bB02, WRM0631cB02, WRM0631dA02, WRM0617aF03, WRM0629bF04. (B) Shown in the table is the
percentage of recombinants in the region that displayed the tat-2(ku452) suppressor phenotype. (C) Protein sequence alignment of a portion of C.
elegans tat-2 and tat-1 (the P-type ATPase most closely related to tat-2), the yeast orthologue, DRS2 and the human orthologue of tat-2, ATP8B1.
Residues shaded in black are identical among all proteins aligned. Residues shaded in gray are identical among two or more of the proteins aligned.
Denoted with arrows and the corresponding allele names are the three amino acids in TAT-2 that are changed in the three suppressor mutants.
doi:10.1371/journal.pgen.1000589.g002
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deficiency-triggered growth arrest
To determine where tat-2 is expressed in C. elegans, we generated
a transcriptional GFP reporter that included approximately 3 kb
of sequence upstream of the tat-2 initiation codon. Consistent with
the report by Lyssenko et al. [17], we also observed that tat-2 is
expressed primarily in the excretory cell, spermatheca and
intestine (Figure S1 and Text S1). ELO-5 is also expressed in
the intestine and several amphid neurons in the head [1]. Since
fatty acids generated in the intestine are likely transported to
various tissues of the body, it is possible that rescue of the elo-5
deletion mutant phenotype depends on TAT-2-mediated effects
on mmBCFAs in non-intestinal tissues. In order to address this, we
first verified that the tat-2 cDNA expressed under the control of the
3-kb promoter described above produces a functional protein by
generating transgenic lines harboring a tat-2Prom::tat-2 cDNA in
the tat-2(ku449);elo-5(gk208) genetic background. The transgenic
worms were assessed for the elo-5(lf) phenotype (second-generation
larval arrest) in the presence of C13ISO and compared to
transgenic tat-2(ku449);elo-5(gk208) worms expressing GFP under
the control of the tat-2 promoter. As shown in Table 2, 99.1% of
the transgenic F1 worms expressing tat-2 cDNA arrested at the L1
stage, whereas 0% of the negative control transgenic F1s arrested
as L1s. This indicated that the tat-2 cDNA expressed under the
control of the 3-kb tat-2 promoter is sufficient to rescue TAT-2
function. Next, we generated several constructs for the tissue-
specific expression of the tat-2 cDNA, and each of these constructs
was injected into tat-2(ku449); elo-5(gk208). The transgenic lines
were then examined for second-generation larval arrest in the
presence of C13ISO and the results are summarized in Table 2.
Expression of tat-2 cDNA from the intestinal-specific ges-1
promoter [27] was able to fully rescue the elo-5 suppression
phenotype of tat-2(ku449);elo-5(gk208), however, tat-2 driven by the
spermathecal promoter, sth-1 [28], the excretory cell promoter,
exc-5 [29], or the hypodermal-specific promoter col-10 [30], was
not able to restore the elo-5 phenotype (Table 2). These results
demonstrate that loss of functional TAT-2 in the intestine is
necessary for suppression of elo-5(gk208). Therefore, TAT-2 acts in
the intestine for its function in C17ISO-defiency-triggered growth
arrest.
TAT-2, but not other TAT genes, is specifically involved in
mmBCFA-mediated growth regulation
To test if the rescue of mmBCFA deficiency was a shared
characteristic of depletion of other aminophospholipid translocases
in C. elegans, we acquired deletion mutations for tat-1(tm1034), tat-
3(tm1275), tat-4(tm1801) and tat-6(ok1984) and checked for rescue
of the elo-5(lf) phenotype. Due to the poor viability of the tat-5
deletion mutant and the penetrant embronyic lethal phenotype
displayed by rrf-3(-) animals on tat-5 RNAi, we treated elo-
5(gk208);rrf-3(ok629) animals with tat-5 RNAi and assayed rescue.
None of these tat mutants rescued the elo-5(lf) phenotype (Table 3).
In addition, we noted that tat-4(tm1801) and tat-6(ok1984) seemed
to have a more severe phenotype in the presence of elo-5(lf),
resulting in death of the tat-4 and tat-6 mutant animals in the first
generation (Table 3). While TAT-2 is the only TAT protein that
plays a prominent negative role in mmBCFA-mediated growth
regulatory functions, it is possible that TAT-4 and TAT-6 play
some positive roles in mmBCFA-involved functions.
We then wanted to test if tat-2(lf) can also affect the growth
defects caused by general fatty acid depletion. We grew tat-
2(tm2332) and wild-type control animals on bacteria expressing
RNAi against either fasn-1, the C. elegans fatty acid synthase
orthologue or fat-2,aD12 fatty acid desaturase involved in the
normal formation of polyunsaturated fatty acids [31,32]. tat-
2(tm2332) exhibited no rescue of the lethality caused by fasn-
1(RNAi) or fat-2(RNAi) (data not shown).
tat-2(lf) suppresses the lethality caused by disrupting
sphingolipid biosynthesis
As mentioned earlier, sphingolipids in C. elegans have been
shown to contain monomethyl branched-chain sphingoid bases
[23]. We reasoned that tat-2(lf) may suppress the mmBCFA
growth defect through suppression of the activity of more complex
lipids that are formed from mmBCFAs, such as sphingolipids. We
explored the idea that TAT-2 may act through its postulated
flippase activity to modulate the activity of one or more
sphingolipids localized in the membrane.
We examined the effects of depleting the C. elegans homolog (sptl-
1) of one of the subunits (SPTLC1) of the mammalian serine
palmitoyl-CoA transferase complex. We found that sptl-1(RNAi)
results in 95.8% lethality in 10 days (Figure 3G). These animals
also displayed an uncoordinated phenotype resulting from the
dead larva within the mother and vacuolization and degradation
of the intestine (Figure 3A and 3C). These results suggest that
sphingolipids are essential for C. elegans survival and development.
Surprisingly, when tat-2(tm2332) animals were grown in the sptl-
1(RNAi) background, 96.3% were alive on day 10 (Figure 3G).
The animals were egg-laying competent and most embryos
developed normally (Figure 3E). A few embryos (.10 per worm)
completed embryonic development inside the eggshell within the
mother, but did not hatch out of the eggshell (data not shown). tat-
2(-);sptl-1(RNAi) laid approximately 45% of the number of eggs
compared to control tat-2(-) worms on the mock RNAi plates, and
Table 3. Effects of mutating five other P-type ATPase in C.
elegans on the elo-5(lf) growth arrest phenotype.
Genotype
% Larvae Past L1 in 2
nd
Generation (n)
(a)
elo-5(gk208)+C13ISO 0 (40)
elo-5(gk208);tat-2(ku452)+C13ISO 99 (44)
elo-5(gk208);tat-1(tm2232)+C13ISO 0.3 (47)
elo-5(RNAi) 0( 2 0 )
elo-5(RNAi); tat-2(tm2332) 100 (40)
elo-5(RNAi); tat-3(tm1275) 0( 2 0 )
elo-5(RNAi); tat-4(tm1801) 0
(b) (18)
elo-5(RNAi); tat-6(ok1984) 0
(c) (46)
Genotype Phenotype
rrf-3(ok629); tat-5(RNAi) embryonic lethal (14)
Rrf-3(ok629); elo-5(gk208); tat-5(RNAi) larval lethal
(d) (14)
Wild-type and mutant strains for the RNAi feeding experiments were grown
from eggs on elo-5(RNAi) and control HT115 plates. Rescue (number of larva
past L1 in the second generation) was assayed on the day 6–7. For the elo-
5(gk208) double mutant experiments, worms were grown from eggs on OP50
bacteria supplemented with 1 mM C13ISO. The numbers of larva past L1 larval
stage were counted on day 6–7. In the RNAi feeding experiments with tat-5
RNAi, rescue of the elo-5(gk208) larval lethal phenotype in the first generation
was assayed.
(a)n=number of plates.
(b)no eggs laid by the P0, suggesting a synthetic sterile effect.
(c)synthetic lethal in the first generation, tat-6(ok1984) on HT115 alone is 50%
embryonic lethal.
(d)in the first generation.
doi:10.1371/journal.pgen.1000589.t003
TAT-2 Role in mmBCFA Function
PLoS Genetics | www.plosgenetics.org 6 August 2009 | Volume 5 | Issue 8 | e1000589Figure 3. tat-2(lf) mutations suppress phenotypes caused by disrupting sphingolipid biosynthesis. (A–F) Images under Nomarski optics
of wild-type or tat-2(tm2332) worms grown from eggs treated with sptl-1(RNAi). Images taken on day 5 of treatment. (A) The sptl-1(RNAi) treated wild-
type adults shown are egg-laying defective which results in an uncoordinated morphology. The progeny are not visible on the plate. (B) The tat-
2(tm2332); sptl-1(RNAi) adults displayed normal movement and gross morphology. Eggs and progeny are visible. (C) An egg-laying defective worm
with a larva (black arrows) hatched inside the mother. (D) Representative adult worm with vacuoles in the body and intestinal lumen (black arrows).
(E) A non-egg-laying defective tat-2(tm2332) worm. (F) Representative tat-2(tm2332) worm with wild-type morphology. (G) Comparison of percent
survival of the P0 generation and F1 generation after 10 days on sptl-1(RNAi)+/2SEM. n=3 experiments with clonal analysis of 20 worms each;
P,.001. Scale bars: (A–B) ,100 mM; (C–F) ,10 mM.
doi:10.1371/journal.pgen.1000589.g003
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F1 larvae remain alive in various larval stages as long as 2 months
but did not continue to propagate. In addition, no vacuoles were
observed in tat-2(tm2332); sptl-1(RNAi) worms (Figure 3F). This
suppression is not likely due to a reduced efficiency of the RNAi
treatment in the tat-2 mutant, since no obvious reduction in RNAi
efficiency was observed when the tat-2 mutant was treated by
RNAi of several other metabolic genes such as fasn-1, spb-1 and acs-
1 (data not shown). These results demonstrate that tat-2 deficiency
not only rescues the growth defects caused by depletion of
C17ISO, but can also partially rescue defects caused by depletion
of sphingolipids.
Since cholesterol and sphingolipids reside together in lipid rafts,
we tested tat-2 mutants for the ability to suppress the cholesterol-
depleted phenotype. We found no rescue of the growth arrest
phenotype caused by cholesterol-depletion in tat-2(tm2332) worms
as compared with wild-type worms (data not shown; [33]). We also
sought to determine if tat-2(tm2332) would be able to rescue
general lipid misregulation phenotypes. When we knocked down
expression of the C. elegans homolog of SREBP gene, C. elegans sbp-
1, which is thought to affect global lipid homeostasis [5], tat-
2(tm2332) mutants showed no differences as compared to control
worms under the same conditions (data not shown). Finally, we
tested the ability of tat-2(-) to alter the phenotype of a deletion
mutant in a C. elegans orthologue of phosphatidylserine synthase,
pssy-2(tm1955), an enzyme that converts phosphatidylcholine to
phosphatidylserine. We found that the depletion of TAT-2 did not
change the sterility phenotype of this mutant (data not shown).
Glycosphingolipids contain C15ISO and C17ISO-
branched fatty acid chains
The rescue of both sphingolipid and C17ISO depletion by tat-2
mutants led us to ask whether there were sphingolipids in elo-5-
depleted worms and if so, what the fatty acid constituents of those
sphingolipids were. Due to the difficulty of analyzing every type of
sphingolipid in C. elegans in various mutant backgrounds, we chose
to isolate glycosphingolipids in synchronized populations of
mutant versus wild-type worms and separate them using thin
layer chromatography (TLC) in the manner described in Griffitts
et al., [34]. The bands representing ceramide-based sphingolipids
with one to four saccharide molecules (as inferred by reference
standards) were scraped from the TLC plates and the fatty acid
side chains were extracted and analyzed by gas chromatography.
The results are displayed in Figure 4. Analysis of wild-type control
worms indicated that C15ISO and C17ISO represent ,20–30%
of the fatty acid chain composition in the glycosphingolipids
obtained in this assay. In the elo-5-depleted worms, the fatty acid
composition in the TLC scrape revealed the combined C15ISO
Figure 4. Glucosylceramides from elo-5(lf) worms lack mmBCFA constituents. Comparison of the fatty acid chains of low complexity
glucosylceramides in 5 different strains as indicated. C15ISO and C17ISO are significantly decreased in the elo-5(RNAi), elo-5(gk208)+C13ISO and tat-
2(tm2332);elo-5(gk208)+C13ISO animals when compared to the wild-type and wild-type +C13ISO (black arrows). The tat-2(tm2332);elo-5(gk208) strain
also contains the unc-5(e53) allele. Data are expressed as percentage of total fatty acids+/2SEM. The data were collected from at least three replicates
for each strain, except tat-2(tm2332); elo-5(gk208)+C13ISO, which had two replicates; P,.001.
doi:10.1371/journal.pgen.1000589.g004
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wild-type worms supplemented with C13ISO showed similar
results. In addition, we noted that the tat-2(lf);elo-5(lf) animals
supplemented with C13ISO had similar results to the elo-5(lf)
animals (Figure 4). This likely rules out the possibility that tat-2(-) is
somehow rescuing the growth defect by altering the incorporation
of mmBCFAs into the fatty acid side-chains of sphingolipids.
When the relative amount of glycosphingolipids in the wild-type
worms was compared with that in the elo-5(RNAi) worms, they
were found to be similar (data not shown). Interestingly, elo-
5(RNAi) worms incorporate other fatty acids into glycosphingo-
lipids in order to compensate for the missing mmBCFAs, with a
trend towards a significant increase in stearic acid (C18:0). We
postulate that the substituted glycosphingolipids are unable to
carry out the essential functions of mmBCFA-containing sphin-
golipids required for post-embryonic growth.
Discussion
Role of TAT-2 in mmBCFA-mediated growth regulation
Little is known about the functions of most of the P-type
ATPases in animals. In this report, we identified a novel
physiological role for a P-type ATPase in a specific lipid-mediated
developmental function. In our previous studies, we showed that
depletion of long monomethyl branched-chain fatty acids by
mutating the elo-5 gene causes C. elegans to robustly arrest their
post-embryonic growth. We show here that loss-of-function
mutations in the putative aminophospholipid translocase TAT-2
are able to overcome this arrest, indicating a link between TAT-2
function at cell membranes and C17ISO-mediated growth
regulation. A straightforward interpretation of the genetic data is
that TAT-2 antagonizes C17ISO function in promoting post-
embryonic growth (Figure 5). Given what is known about this
family of P-type ATPases, we speculate that TAT-2 may regulate
the function of a lipid of more complex structure that mediates the
C17ISO functions. TAT-2 could function to direct the localization
of this lipid through its potential lipid translocase activity or
through its potential role in secretory and/or endocytic trafficking.
Our work presented in this paper also suggests that such a lipid
affected by TAT-2 function may be a sphingolipid. We have found
that tat-2 mutations also partially suppress the developmental
defects caused by RNAi of a subunit of the serine-palmitoyl
transferase complex that is required for sphingolipid biosynthesis.
We further determined that ceramide-based glycosphingolipids
contain a significant proportion of C15ISO and C17ISO in their
fatty acid side chains and that these are depleted in an elo-5(lf)
background. Although it is currently corollary evidence, these
results strongly implicate a functional linkage between mmBCFAs
and sphingolipids.
In a recent report, mutations in tat-2, tat-3 and tat-4 genes were
shown to enhance the sensitivity of C. elgans to cholesterol
deficiency, implicating the roles of these P-type ATPases in
cholesterol metabolism [17]. These roles appear to be distinct from
the tat-2 function in C17ISO-mediated growth regulation for two
reasons. First, regarding the effects on the animal growth, the
enhancement of the defects caused by cholesterol deficiency is the
opposite to the rescue of the defects caused by C17ISO depletion
or by disrupting sphingolipid biosynthesis. Second, the tat-2
mutant effect on C17ISO function is highly specific to this
particular P-type ATPase; none of the other tat genes has any
observable effects (Table 3).
Disruption of mmBCFA biosynthesis causes multiple develop-
mental defects that include, but are not limited to L1 growth arrest
[1]. There is a clear functional difference between the shorter
mmBCFA C13ISO and the long chain mmBCFA C17ISO [2].
Low levels of exogenous C13ISO (1 mM) can overcome almost all
developmental defects caused by depleting endogenous mmBCFAs
in elo-5 mutants except the L1 growth arrest that can be overcome
by feeding a low level of dietary C17ISO or a high level of
C13ISO (10 mM). Our data in this study indicate that tat-2
mutations can suppress the L1 arrest phenotype but not bypass the
requirement of mmBCFA for some other developmental functions.
In our typical L1 arrest assay, the elo-5(lf) mutants were grown on
plates supplemented with a low level of C13ISO. These results
indicate that C17ISO, not C13ISO, plays the major role in
mediating development past the first larval stage in normal worms,
and that C13ISO, at a very high concentration, can function as
C17ISO for the growth regulatory function. The latter raises the
possibility that the tat-2 mutations may suppress the growth arrest
by dramatically changing the dynamics or efficiency of C13ISO.
For example, tat-2 mutant worms may be able to absorb a higher
level of exogenously provided mmBCFAs, leading to a higher
internal C13ISO concentration. Alternatively, in the absence of
TAT-2, the subcellular distribution of C13ISO may be altered
through a novel mechanism in such a way that allows the molecule
to function as effectively as C17ISO.
Several lines of evidence argue that the above scenarios are
unlikely. First, under conditions without any mmBCFA supple-
ment, elo-5(-);tat-2(-) mutants can typically bypass the L1 arrest
and grow another generation before the animals arrest at various
larval stages due to other developmental defects (Table 1). In
addition, when elo-5(RNAi) is applied to wild-type worms, L1
arrest is observed for the F1 animals. However, when elo-5(RNAi)
is applied to tat-2(-) mutants without any mmBCFA supplemen-
tation, the animals can actually propagate multiple generations
withoutdevelopmentalarrest(Table1). Theseresultssuggestthat
the tat-2 mutations are able to overcome the L1 arrest from
depleting C17ISO without the presence of C13ISO. Second, we
found that internal C13ISO levels were not significantly different
between tat-2 and wild-type worms, arguing against the
possibility that a tat-2 mutation enhances the absorption of
C13ISO into animal cells. Third, the C15ISO and C17ISO
levels are similar in the elo-5;tat-2 double mutants when
compared to the elo-5 single mutant, inconsistent with the idea
that a tat-2 mutation can increase the stability of mmBCFAs.
Finally, if the C17ISO function in post-embryonic growth is
mediated by a glycosphingolipid as we proposed above, the fact
that tat-2 mutations can also suppress the defects in sptl-1(RNAi)
worms does not appear to be consistent with the effect of the tat-2
mutations altering the subcellular distribution and effectiveness
of C13ISO.
Figure 5. Proposed functional relationship between C17ISO
and TAT-2 in promoting post-embryonic growth and develop-
ment. C17ISO is required for post-embryonic growth and develop-
ment. TAT-2 antagonizes this function in intestinal cells, possibly by
affecting the process of generating an effective mmBCFA-containing
lipid molecule in proper cellular locations.
doi:10.1371/journal.pgen.1000589.g005
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post-embryonic growth
Our previous work indicated that the mmBCFA C17ISO can
move from the intestinal cells of adult worms into their eggs [2].
Therefore, mmBCFAproduced in agiventissue canpotentiallymove
to other tissues, making it difficult to determine in which tissue the
mmBCFA is promoting post-embryonic growth. In this study, by
expressing the TAT-2 protein behind tissue-specific promoters, we
were able to show that expression of TAT-2 in intestinal cells is
sufficient and likely necessary for TAT-2 to execute its role in
mmBCFA-mediated regulatory function (Table 2). The latter
statement is supported by the data that the expression of TAT-2 in
three other tissues, including the major hypodermal tissue, could not
rescue the mutant phenotype. Consistent with this, the mmBCFA
biosynthesis enzymes ELO-5, ELO-6 and ACS-1 are all expressed at
high levels in intestinal cells. These results suggest that the post-
embryonic growth regulatory function of mmBCFAs and TAT-2
primarily occurs in intestinal cells, where exogenic mmBCFAs would
have been first absorbed during feeding. However, because depleting
C17ISO causes arrest of all post-embryonic tissues including muscle
cells and hypodermal cells [2], a growth inhibitory signal such as an
increase in cki-1 expression that may be triggered by C17ISO
deficiency may be able to spread from intestinal cells to neighboring
cells. The nature of this high-order lipid molecule and how this
molecule executes this signaling process are currently not known.
Additional genetic screening and biochemical analyses are being
carried out to search for the answers.
Materials and Methods
General C. elegans maintenance and strains
All strains were maintained at 20 uC on OP50 bacteria on
nematode growth media (NGM) according to standard protocol
[35] unless RNAi treatment was performed. The wild-type strain
was Bristol strain, N2. Mutant strains used were elo-5(gk208)IV, tat-
2(ku449)IV, tat-2(ku450)IV, tat-2(ku452)IV, tat-2(tm2332)IV, tat-
2(1773)IV, tat-1(tm1034)III, tat-3(tm1275)III, tat-4(tm1801)II, tat-
6(ok1984)V, rrf-3(ok629)II, dpy-13(e184)IV and unc-5(e53)IV. The
elo-5(gk208)IV, tat-6(ok1984)V, rrf-3(ok629)II, dpy-13(e184)IV and
unc-5(e53)IV strains were obtained from the C. elegans Gene
Knockout Consortium. The tat-2(tm2332)IV, tat-2(1773)IV, tat-
1(tm1034)III, tat-3(tm1275)III, tat-4(tm1801)II, pssy-2(tm1955)III
deletion strains were obtained from the National Bioresource
Project in Japan. The CB4856 Hawaiian strain was used in SNP
mapping procedures.
The elo-5(gk208)IV strain and suppressor and double mutant
strains with the elo-5(gk208)IV allele were maintained on OP50
bacteria supplemented with the mmBCFA-producing S. maltophilia
bacteria [1].
elo-5(lf) suppressor screen
elo-5(gk208) L4-staged P0 worms grown in the presence of
2 mM C17ISO were mutagenized with EMS. Mutagenized F1
worms were grown to gravid adulthood on 2 mM C17ISO-
supplemented plates and F2 eggs released by alkaline hypochlorite
treatment were plated on 1 mM C13ISO-supplemented plates.
Suppressor candidates were determined by the ability of their
progeny to grow past the L1-stage. From ,8000 haploid genomes,
five suppressor mutants were isolated. Three tat-2 alleles, ku449,
ku450, ku452, were isolated in separate rounds of screening.
Phenotypic scoring
For all survival and rescue experiments, strains were
maintained on plates containing S. maltophilia to provide an
exogenous source of mmBCFAs. In order to score for elo-5
growth arrest phenotypes, worms were collected from S.
maltophilia containing plates and subjected to alkaline hypchlorite
treatment to eliminate contaminating S. maltophilia and eggs were
collected. Clean eggs were then spotted onto AMP plates spotted
with HT115 transformed with empty vector (pPD 129.36)
without mmBCFA supplements or AMP plates spotted with
HT115 transformed with empty vector to which indicated
concentrations of C13ISO were added from a 10 mM stock in
DMSO. Following several days of growth, worms were scored for
their developmental stage. HT115, when transformed with pPD
129.36, was used in these experiments because of its resistance to
ampicilin, which aids in preventing the growth of contaminating
bacteria that can interfere with accurate rescue scoring.
Phenotypes on standard OP50 were identical.
In the sptl-1(RNAi) experiments, gravid wild-type or tat-
2(tm2332) adults were bleached and eggs were spotted on bacteria
expressing sptl-1(RNAi). After 2 days of development, 20 single
worms were cloned to individual sptl-1(RNAi) plates and survival of
the P0 and F1 generation was quantified as a percent of the total
number of animals scored. This was repeated 3 times, in parallel
for wild-type and tat-2(tm2332) mutant worms. An unpaired
Student’s t-test was used to compare the values.
Analysis of fatty acid composition by gas
chromatography
Lipid extraction, fatty acid methyl ester preparation and gas
chromatography were performed in the manner described
[1,2,36]. Worms grown from eggs isolated by bleaching were
spotted on plates with: 1) HT115 (transformed with pPD129.36),
2) HT115 supplemented with C13ISO where final concentration
of the fatty acid in the bacteria culture was equal to 1 mM, or 3)
HT115 transformed with pPD129.36 vector expressing double-
stranded RNA against the indicated genes. Adults and their L1
progeny were collected with water, washed and frozen until use for
lipid extraction. For each type of sample, five replicates were
assayed.
For analysis of the fatty acid chains in glycosphingolipids,
glycosphingolipids were first isolated from worm extracts and
separated by TLC as described below. Bands representing
glycosphingolipids were scraped from the silica TLC plates.
Extraction, methyl ester preparation and gas chromatography of
fatty acids from TLC-fractionated lipids were performed as
outlined above. In these experiments, three replicates were done
for each sample type, except where noted. For both analyses,
average, standard deviation and standard error were calculated
using the Excel program. Statistical significance was determined
using the single-factor ANOVA method.
Molecular cloning of tat-2
A SNP mapping method [37] was used to map tat-2(ku452) near
the middle of chromosome IV. Due to the proximity of tat-2(ku452)
to the elo-5(gk208) mutation, which was necessary to have in the
background to observe the suppressor phenotype, the mapping
strategy was switched to traditional three-pointmapping, narrowing
the region containing ku452 to between the markers dpy-13 and unc-
5. Recombinants were generated by crossing ku452 to a dpy-
13(e184); elo-5(gk208); unc-5(e53) strain. F2 Unc non-Dpy and Dpy
non-Unc animals were isolated, homozygosed and scored for the
presence of ku452 suppressor phenotype. Of these recombinants,
11/23 Unc non-Dpy and 45/63 Dpy non-Unc recombinants
retained theku452 mutation. Poolsoffour fosmids(15 ng/mL) along
with sur-5::GFP (90 ng/mL) [38] were co-injected into ku452 worms
and examined for rescue. Due to the incomplete fosmid coverage of
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below) was injected and rescue was observed. The coding region of
tat-2 was PCR-amplified from ku449, ku450 and ku452 mutants and
sequenced to identify the molecular legions.
RNAi feeding
HT115 bacteria expressing double-stranded RNA from the
indicated genes was seeded onto NGM agar plates with IPTG and
ampicilin for feeding [39]. Bacterial strains were obtained from the
C. elegans genome-wide RNAi feeding library (Geneservice). Eggs
isolated from the indicated C elegans strains by hypochlorite
treatment were allowed to develop at 20uC with the RNAi feeding
strains as their food source. Controls were fed with HT115
transformed with an empty pPD129.36 plasmid.
Expression, rescue, and heat shock constructs
The tat-2 transcriptional reporter construct, pJB10, was
generated by PCR amplification of 3 kb upstream of the tat-2
initiation codon from N2 genomic DNA using the following
primers: For 59-AAGGATCCTTTCCATGACTCACGCTG-
39,R e v5 9-AACCCGGGCCCTCCGCCACCTCCTTT-39.
The PCR product was ethanol precipitated, digested with
BamHI and SmaI and ligated into the GFP vector pPD95.69
(generously provided by the Fire lab). The resulting construct,
pJB10, was co-injected with pBluescript into the following
strains: N2, elo-5(gk208), elo-5(gk208);ku452,a n dtat-2(tm2332)
to obtain transgenic lines. Multiple lines were generated in each
strain to verify the expression. A construct expressing tat-2
cDNA under the native 3 kb tat-2 promoter was generated by
first cloning the promoter into pPD49.26 using the same
primers and procedure described above for pJB10. The
resulting construct, pJB14, was subsequently used to subclone
the tat-2 cDNA. A first strand cDNA synthesis reaction was
carried out using a gene-specific tat-2 primer and RNA isolated
from N2 worms as template. The tat-2 cDNA was then PCR
amplified from the first strand reaction using the following
primers: For 59-CACACCCGGGATGTTCAGTTGGTTGC-
CATG-39,R e v5 9-AAACCCGGGTTAAAGGCGAGTGAT-
TACGTCTG-39. The PCR product was ligated into pJB14 as a
SmaI fragment to yield pJB18. To generate tissue-specific
constructs tat-2 cDNA was amplified from the first strand
reaction described above using primers: For 59-CACAG-
GATCCATGTTCAGTTGGTTGCCATG-39,R e v5 9-AAAC-
CCGGGTTAAAGGCGAGTGATTACGTCTG-39.T h eP C R
product was ligated into pPD49.26 as a BamHI/SmaI fragment
to generate pJB15. Tissue-specific promoters were PCR
amplified as follows: 1.8 kb upstream of the ges-1 start codon,
2.2 kb upstream of the exc-5 start codon and 3.4 kb upstream of
the sth-1 start codon. Each PCR product was purified, digested
and subcloned separately into pJB15 upstream of the tat-2
cDNA start codon. For the heat shock construct, pES11, the tat-
2 cDNA generated above was cloned into the heat shock
promoter vector, pPD49.83 as a BamHI/SmaI fragment.
pES11 was co-injected with pBluescript and with a sur5::GFP
marker (Yochem et al. 1998) construct into N2 worms.
Microscopy
Analysis of GFP expression and phenotypic abnormalities were
conducted with Nomarski optics using a Zeiss Axioplan2
microscope and a C4742-95 CCD camera. Plate phenotypes were
observed through a Leica MZ16F dissecting microscope and
pictures were taken with a Canon Powershot A620 digital camera
with a Canon Scopetronix Maxview Plus adapter.
Glycosphingolipid extraction and thin-layer
chromatography
Lower phase lipids were isolated and resolved via TLC in the
manner described [34] from the indicated strains. In short, a 500–
800 mL pellet of packed worms was used as starting material. The
lower phase extracts were re-suspended in 500–800 mL volume of
1:1 chloroform:methanol. HPTLC plate (Supelco, Bellefonte, PA)
lanes were loaded with 50 mL volumes of individual samples.
Seven lanes were done for each sample type. The plates were
developed in a TLC chamber containing 45:18:3 chloroform:-
methanol:water. Glycosphingolipids were resolved with an orcin-
ol/sulfuric acid stain, followed by heating for 120 uC for
10 minutes. As mentioned in the results, a neutral glycosphingo-
lipid standard was used for comparison. After cooling, the
brownish-red bands corresponding to glycolipids were scraped
from the plate and the bands from the seven lanes were pooled to
obtain adequate material for fatty acid extraction and GC analysis.
Supporting Information
Figure S1 TAT-2 is primarily expressed in the intestine,
spermatheca and excretory cell (A, D, G, J,) DIC images, (B, E,
H, K) fluorescence images and (C, F, I, L) merged images of
various staged animals expressing the tat-2 Prom::GFP transgene.
(A–C) An early staged larvae expressing GFP in the excretory cell
(white arrow), pharyngeal muscle cells (black arrows), as well as
strongly in the intestine. The result is mostly consistent with a
previous analysis [17]. (D–F) Shown is the spermathecal
expression in an adult animal. (G–I) The expression in the uterus
of an adult animal (white arrow points to the uterus surrounding a
developing embryo) is shown. (J–L) tat-2Prom::GFP is expressed in
an amphid sheath cell (white arrow) extending along the head of
an L1 larvae.
Found at: doi:10.1371/journal.pgen.1000589.s001 (6.50 MB TIF)
Text S1 Supplemental data.
Found at: doi:10.1371/journal.pgen.1000589.s002 (0.03 MB
DOC)
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